1 |
Meschia JF, Worrall BB, Rich SS. Genetic susceptibility to ischemic stroke [J]. Nat Rev Neurol, 2011, 7(7): 369-378.
|
2 |
Shamsara J, Mohammadpour AH, Behravan J, et al. Pentoxifylline decreases soluble CD40 ligand concentration and CD40 gene expression in coronary artery disease patients [J]. Immunopharmacol Immunotoxicol, 2012, 34(3): 523-529.
|
3 |
Antoniades C, Bakogiannis C, Tousoulis D, et al. The CD40/CD40 ligand system: linking inflammation with atherothrombosis [J]. J Am Coll Cardiol, 2009, 54(8): 669-677.
|
4 |
Pamukcu B, Lip GY, Snezhitskiy V, et al. The CD40-CD40L system in cardiovascular disease [J]. Ann Med, 2011, 43(5): 331-340.
|
5 |
García-Bermúdez M, González-Juanatey C, López-Mejías R, et al. AB0021 Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in spanish rheumatoid arthritis patients [J]. PLoS One, 2012, 7(11): e49214.
|
6 |
Schönbeck U, Libby P. CD40 signaling and plaque instability [J]. Circ Res, 2001, 89(12): 1092-1103.
|
7 |
Tian C, Qin W, Li L, et al. A common polymorphism in CD40 Kozak sequence (-1C/T) is associated with acute coronary syndrome [J]. Biomed Pharmacother, 2010, 64(3): 191-194.
|
8 |
Wang M, Li Y, Li W, et al. The CD40 gene polymorphism rs1883832 is associated with risk of acute coronary syndrome in a Chinese case-control study [J]. DNA Cell Biol, 2011, 30(3): 173-178.
|
9 |
Fong SW, Few LL, See Too WC, et al. Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease [J]. BMC Res Notes, 2015, 8: 679.
|
10 |
YanYun P, Wang S, Yang J, et al. Interruption of CD40 pathway improves efficacy of transplanted endothelial progenitor cells in monocrotaline induced pulmonary arterial hypertension [J]. Cell Physiol Biochem, 2015, 36(2): 683-696.
|
11 |
Nakayama Y, Brinkman CC, Bromberg JS. Murine fibroblastic reticular cells from lymph node interact with CD4+ T cells through CD40-CD40L [J]. Transplantation, 2015, 99(8): 1561-1567.
|
12 |
Wang DG, Fan JB, Siao CJ, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome [J]. Science, 1998, 280(5366): 1077-1082.
|
13 |
Chen JM, Guo J, Wei CD, et al. The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus [J]. BMC Genet, 2015, 16: 121.
|
14 |
Sokolova EA, Malkova NA, Korobko DS, et al. Association of SNPs of CD40 gene with multiple sclerosis in russians [J]. PLoS One, 2013, 8(4): e61032.
|
15 |
Zhou C, Jin X, Tang J, et al. Association of CD40 -1C/T polymorphism in the 5′-untranslated region with chronic HBV infection [J]. Cell Physiol Biochem, 2015, 35(1): 83-91.
|
16 |
Ma Y, Wang SX, Liu Y, et al. Single nucleotide polymorphism of CD40 in the 5′-untranslated region is associated with ischemic stroke [J]. Gene, 2013, 529(2): 257-261.
|
17 |
Jacobson EM, Concepcion E, Oashi T, et al. A Graves′ disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology [J]. Endocrinology, 2005, 146(6): 2684-2691.
|
18 |
Zhang B, Wu T, Song C, et al. Association of CD40-1C/T polymorphism with cerebral infarction susceptibility and its effect on sCD40L in Chinese population [J]. Int Immunopharmacol, 2013, 16(4): 461-465.
|
19 |
陈健明, 黄华佗, 袁秋然, 等. 白细胞分化抗原-40基因SNP及其血清水平与缺血性脑卒中的相关性 [J]. 中华预防医学杂志, 2016, 50(3): 239-243.
|
20 |
Huang HT, Guo J, Xiang Y, et al. A SNP in 5′untranslated region of CD40 gene is associated with an increased risk of ischemic stroke in a Chinese population: a case-control study [J]. Genet Mol Biol, 2017, 40(2): 442-449.
|
21 |
Zhang B, Chen M, Yang H, et al. Evidence for involvement of the CD40/CD40L system in post-stroke epilepsy [J]. Neurosci Lett, 2014, 567(5): 6-10.
|
22 |
del Río-Espínola A, Fernández-Cadenas I, Rubiera M, et al. CD40-1C>T polymorphism (rs1883832) is associated with brain vessel reocclusion after fibrinolysis in ischemic stroke [J]. Pharmacogenomics, 2010, 11(6): 763-772.
|
23 |
Kassner SS, Kollmar R, Bonaterra GA, et al. The early immunological response to acute ischemic stroke: differential gene expression in subpopulations of mononuclear cells [J]. Neuroscience, 2009, 160(2): 394-401.
|
24 |
Garlichs CD, Kozina S, Fateh-Moghadam S, et al. Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia [J]. Stroke, 2003, 34(6): 1412-1418.
|
25 |
Chen Y, Chen J, Xiong Y, et al. Internalization of CD40 regulates its signal transduction in vascular endothelial cells [J]. Biochem Biophys Res Commun, 2006, 345(1): 106-117.
|
26 |
de Lemos JA, Zirlik A, Schönbeck U, et al. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study [J]. Arterioscler Thromb Vasc Biol, 2005, 25(10): 2192-2196.
|
27 |
Tuttolomondo A, Di Raimondo D, Di Sciacca R, et al. Fetuin-A and CD40 L plasma levels in acute ischemic stroke: Differences in relation to TOAST subtype and correlation with clinical and laboratory variables [J]. Atherosclerosis, 2010, 208(1): 290-296.
|
28 |
Lukasik M, Dworacki G, Michalak S, et al. Chronic hyper-reactivity of platelets resulting in enhanced monocyte recruitment in patients after ischaemic stroke [J]. Platelets, 2012, 23(2): 132-142.
|
29 |
Wang JH, Zhang YW, Zhang P, et al. CD40 ligand as a potential biomarker for atherosclerotic instability [J]. Neurol Res, 2013, 35(7): 693-700.
|
30 |
Lorente L, Martín MM, González-Rivero AF, et al. Association between serum soluble CD154 levels and mortality in patients with malignant middle cerebral artery infarction [J]. Int J Mol Sci, 2015, 16(6): 12147-12158.
|
31 |
Wang Y, Zhao X, Liu L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study [J]. Stroke, 2014, 45(3): 663-669.
|
32 |
Wang YJ, Gong ZQ, Bi XM, et al. Correlation of plasma soluble cluster of differentiation 40 ligand, alpha fetoprotein A, and pregnancy-associated plasma protein A with carotid plaque in patients with ischemic stroke [J]. Genet Mol Res, 2015, 14(3): 8091-8099.
|
33 |
Li J, Wang Y, Lin J, et al. Soluble CD40L is a useful marker to predict future strokes in patients with minor stroke and transient ischemic attack [J]. Stroke, 2015, 46(7): 1990-1992.
|
34 |
Ma Y, Wang SX, Liu Y, et al. Single nucleotide polymorphism of CD40 in the 5′-untranslated region is associated with ischemic stroke [J]. Gene, 2013, 529(2): 257-261.
|
35 |
马丽书, 李东芳. CD40-1C/T基因多态性与大动脉粥样硬化性卒中的相关性 [J]. 国际脑血管病杂志, 2012, 20(3): 177-181.
|